Nicholas consolidated Q3 net at Rs 9.68cr

Nicholas Piramal India today reported a consolidated net profit of Rs 9.68 crore for the third quarter ended December 31, 2005 as against Rs 77.69 crore in Q3FY05.

According to a release issued by the company to the BSE today, total income moved up to Rs 406.02 crore Q3FY06 from Rs 347.31 crore in Q3FY05.

"The results for the quarter ended December 31, 2005 are not strictly comparable with the figures of the corresponding period of the previous year as the current quarter's figure include operations of the global inhalation anaesthetics (IA) business of Rhodia, pursuant to its acquisition by the company w.e.f January 10, 2005, and operations of the pharmaceuticals business of Avecia following its acquisition w.e.f December 3, 2005," the release added.

The quarter under review also includes operations of NPIL - Dr. Golwilkar Laboratories only for the period April 1, 2005 to June 30, 2005 pursuant to its sale w.e.f June 30, 2005, and does not include the operation of certain injectible and antiseptic brands that were assigned to a third party w.e.f September 17, 2005, the release added.